Bio-Techne

Yahoo Finance • yesterday

Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus

Wall Street’s major market averages concluded higher on Friday as investors reacted to the latest PCE inflation report, which came in hotter than expected. The tech-focused Nasdaq Composite ended +0.9%. At the same time, the benchmark S&P... Full story

Yahoo Finance • 7 days ago

Bio-Techne's Ella Immunoassay Platform Receives CE-IVD Marking In EU

(RTTNews) - Bio-Techne Corp. (TECH) said its Ella benchtop immunoassay platform has received CE-IVD marking and is now available for clinical use across the European Union. The CE-IVD certification allows hospitals, clinical laboratories... Full story

Yahoo Finance • 7 days ago

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time Provides confidenc... Full story

Yahoo Finance • 19 days ago

Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ...

This article first appeared on GuruFocus. Adjusted EPS: $0.46, up 10% year-over-year. GAAP EPS: $0.24, up from $0.22 in the prior year period. Total Revenue: $295.9 million, flat year-over-year on both an organic and reported basis. Adjus... Full story

Yahoo Finance • 19 days ago

Bio-Techne Q2 Earnings Call Highlights

Bio-Techne logo Key Points Bio‑Techne reported organic revenue flat in Q2 as strength from large pharma was offset by softness in emerging biotech and U.S. academia and a near‑term pause in GMP reagent buys from two large cell‑therapy cu... Full story

Yahoo Finance • 19 days ago

Bio-Techne (TECH) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, February 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Kim Kelderman Chief Financial Officer — James T. Hippel Full Conference Call Transcript Kim Kel... Full story

Yahoo Finance • 19 days ago

Bio-Techne Q2 26 Earnings Conference Call At 9:00 AM ET

(RTTNews) - Bio-Techne Corp (TECH) will host a conference call at 9:00 AM ET on February 4, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.bio-techne.com/ir-calendar To listen to the call... Full story

Yahoo Finance • 2 months ago

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 23, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13,... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus

Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) and the Nasdaq (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) ending the week in the red as the AI trade came under... Full story

Yahoo Finance • 2 months ago

Here’s Why BioTechne (TECH) Traded Lower in Q3

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the market’s concentration persists, with a few... Full story

Yahoo Finance • 3 months ago

Bio-Techne Announces Expanded Launch Of Next-Generation Leo System

(RTTNews) - Bio-Techne Corp. (TECH), Tuesday announced the expanded launch and first shipment of its next-generation Leo System, expecting to deliver unmatched precision and efficiency in protein analysis. Powered by Simple Western Techno... Full story

Yahoo Finance • 3 months ago

Bio-Techne Corporation (TECH): A Bull Case Theory

We came across a bullish thesis on Bio-Techne Corporation on Valueinvestorsclub.com by rab. In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation's share was trading at $64.63 as of November 26th. TECH’s trai... Full story

Yahoo Finance • 3 months ago

Bio-Techne (TECH): Evaluating Valuation After ACA Subsidy Extension Boosts Market Sentiment

Bio-Techne (TECH) stock saw a quick boost as investors responded to reports that the Trump administration is considering a two-year extension of Affordable Care Act subsidies. This development is easing some regulatory uncertainty for the... Full story

Yahoo Finance • 3 months ago

Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government financial aids to help... Full story

Yahoo Finance • 3 months ago

Is Bio-Techne Corporation (TECH) a High-Quality Growth-Oriented Compounder Within The Healthcare Sector?

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an environment of shifting monetary policy, stabiliz... Full story

Yahoo Finance • 3 months ago

Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025

mdxhealth Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 million Adjusted EBITDA profitability of $1.0 million for Q3 Acquisition of ExoDx business f... Full story

Yahoo Finance • 4 months ago

Bio-Techne (TECH) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. Date Nov. 5, 2025, 9:00 a.m. ET Call participants President and Chief Executive Officer — Kim Kelderman Chief Financial Officer — James T. Hippel Need a quote from a Motley Fool analyst? Email pr@fool.c... Full story

Yahoo Finance • 4 months ago

Bio-Techne Corp. Q1 Profit Increases, Inline With Estimates

(RTTNews) - Bio-Techne Corp. (TECH) reported a profit for its first quarter that Increases, from the same period last year in line with the Street estimates. The company's bottom line totaled $38.18 million, or $0.24 per share. This comp... Full story

Yahoo Finance • 4 months ago

ClearBridge Mid Cap Strategy outperforms benchmark in Q3, adds QXO and Bio-Techne, exits ATS

[Woman putting savings in a white piggy bank.] Guido Mieth ClearBridge Mid Cap Strategy outperformed its Russell Midcap Index during the third quarter, driven by standout stock selection in consumer staples and health care. The Strategy... Full story

Yahoo Finance • 4 months ago

Seeking Alpha's healthcare quant picks ahead of Q3 earnings: McKesson, Incyte top-rated stocks

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]), which tracks the... Full story